AR and prostate carcinoma: Cell thermal shift assays revealedthat 5-H-Y directly binds to AR and acts as an AR antagonist.In contrast, cisplatin, despite forming aggregates with AR, did notshow a proportional inhibitory effect on prostate cancer cell proliferationin accordance with AR expression level.